Heinrich Burkhardt

1.2k total citations
66 papers, 585 citations indexed

About

Heinrich Burkhardt is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Heinrich Burkhardt has authored 66 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Heinrich Burkhardt's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Reproductive Physiology in Livestock (6 papers). Heinrich Burkhardt is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Reproductive Physiology in Livestock (6 papers). Heinrich Burkhardt collaborates with scholars based in Germany, Switzerland and United States. Heinrich Burkhardt's co-authors include Martin Wehling, R. Gladisch, Farhad Pazan, N. Gretz, Helmut Frohnhofen, Gaby Hirsbrunner, Christel Weiß, U Küpfer, Adrian Steiner and Norbert Gretz and has published in prestigious journals such as Diabetologia, Archives of Disease in Childhood and Age and Ageing.

In The Last Decade

Heinrich Burkhardt

61 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heinrich Burkhardt Germany 14 178 98 90 87 73 66 585
William J. Spruill United States 13 58 0.3× 146 1.5× 66 0.7× 52 0.6× 34 547
Colin Weaver Canada 9 18 0.1× 45 0.5× 76 0.8× 32 0.4× 3 0.0× 25 1.2k
Megan Templin United States 15 131 0.7× 92 0.9× 8 0.1× 81 0.9× 35 588
Angeline M. Carlson United States 14 93 0.5× 32 0.3× 9 0.1× 74 0.9× 38 648
Mireia Puig Spain 15 56 0.3× 174 1.8× 14 0.2× 27 0.3× 79 625
Jaclyn M. LeBlanc United States 13 82 0.5× 88 0.9× 53 0.6× 9 0.1× 26 492
Marina Petrović Serbia 12 95 0.5× 69 0.7× 7 0.1× 55 0.6× 2 0.0× 65 585
Noel Somasundaram Sri Lanka 14 41 0.2× 69 0.7× 20 0.2× 56 0.6× 1 0.0× 70 724
Shoroq M. Altawalbeh Jordan 10 98 0.6× 33 0.3× 46 0.5× 64 0.7× 51 338
P.-O. Lang Switzerland 15 224 1.3× 50 0.5× 4 0.0× 87 1.0× 4 0.1× 45 697

Countries citing papers authored by Heinrich Burkhardt

Since Specialization
Citations

This map shows the geographic impact of Heinrich Burkhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinrich Burkhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinrich Burkhardt more than expected).

Fields of papers citing papers by Heinrich Burkhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinrich Burkhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinrich Burkhardt. The network helps show where Heinrich Burkhardt may publish in the future.

Co-authorship network of co-authors of Heinrich Burkhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Heinrich Burkhardt. A scholar is included among the top collaborators of Heinrich Burkhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinrich Burkhardt. Heinrich Burkhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Burkhardt, Heinrich. (2021). Polypharmazie – Was tun?. DMW - Deutsche Medizinische Wochenschrift. 146(1). 15–22.
3.
Bahat, Gülistan, Birkan İlhan, Tuğba Erdoğan, et al.. (2021). International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study. Drugs & Aging. 38(6). 513–521. 20 indexed citations
4.
Burkhardt, Heinrich, et al.. (2020). Diagnostic efficacy of bedside ultrasound to detect dehydration in older patients attending an emergency care unit. Zeitschrift für Gerontologie und Geriatrie. 54(2). 130–135. 6 indexed citations
5.
Burkhardt, Heinrich, et al.. (2019). Multicomponent, nonpharmacological delirium interventions for older inpatients. Zeitschrift für Gerontologie und Geriatrie. 52(S4). 229–242. 16 indexed citations
6.
Burkhardt, Heinrich. (2019). Umgang mit Multimorbidität und Multimedikation. 3 indexed citations
7.
Pazan, Farhad, et al.. (2017). Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments. European Journal of Clinical Pharmacology. 74(3). 339–347. 16 indexed citations
8.
Wehling, Martin, et al.. (2015). P-426: Clinical validation of the FORTA (Fit fOR The Aged) List in a prospective randomized controlled clinical study. European Geriatric Medicine. 6. S146–S146. 1 indexed citations
9.
Aringer, Martin, Ulf Müller‐Ladner, Heinrich Burkhardt, et al.. (2015). Gemeinsame deutschsprachige Nomenklatur für die systemische Sklerose. Zeitschrift für Rheumatologie. 74(2). 100–103. 6 indexed citations
10.
Kalden, Joachim R., Heinrich Burkhardt, Erika Gromnica‐Ihle, et al.. (2011). Strategien zur verbesserten Versorgung von Menschen mit der Volkskrankheit „Rheuma“ am Beispiel der rheumatoiden Arthritis. Zeitschrift für Rheumatologie. 70(8). 641–650. 6 indexed citations
11.
Harenberg, Job, Rupert Bauersachs, C. Diehm, et al.. (2010). Antikoagulation im Alter. Der Internist. 51(11). 1446–1455. 3 indexed citations
12.
Wehling, Martin & Heinrich Burkhardt. (2010). Arzneitherapie für Ältere. 14 indexed citations
13.
Burkhardt, Heinrich, Martin Wehling, & R. Gladisch. (2007). Pharmakotherapie älterer Patienten. Der Internist. 48(11). 1220–1231. 6 indexed citations
14.
Burkhardt, Heinrich, et al.. (2005). Risk factors of worsening renal function in hospitalized elderly patients. Journal of Nephrology. 18(2). 166–173. 9 indexed citations
15.
Hirsbrunner, Gaby, et al.. (2003). Effect of prostaglandin E2, dl-cloprostenol, and prostaglandin E2 in combination with d-cloprostenol on uterine motility during diestrus in experimental cows. Animal Reproduction Science. 79(1-2). 17–32. 23 indexed citations
16.
Burkhardt, Heinrich & R. Gladisch. (2003). Pharmakotherapie des �lteren Menschen aus klinischer Sicht. Der Internist. 44(8). 959–967. 8 indexed citations
17.
Burkhardt, Heinrich, et al.. (2003). [Desire for death-results of a pilot study with acute geriatric patients].. PubMed. 36(5). 392–400. 3 indexed citations
18.
Burkhardt, Heinrich, et al.. (1977). Untersuchung der Gerinnungsproteine im Brandblaseninhalt bei schweren Verbrennungen. Annals of Hematology. 35(3). 241–246. 2 indexed citations
19.
Melani, F., et al.. (1969). Einfluß der Galaktose auf die Insulinsekretion beim Menschen. 3 indexed citations
20.
Burkhardt, Heinrich, et al.. (1968). Freie Galaktose im Liquor cerebrospinalis: Klinisch-experimentelle Untersuchung zur Frage des Vorkommens und der Blut-Liquorschranke der Galaktose. Journal of Molecular Medicine. 46(24). 1311–1312.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Spruill Breakdown of academic impact, for papers by Colin Weaver Breakdown of academic impact, for papers by Megan Templin Breakdown of academic impact, for papers by Angeline M. Carlson Breakdown of academic impact, for papers by Mireia Puig Breakdown of academic impact, for papers by Jaclyn M. LeBlanc Breakdown of academic impact, for papers by Marina Petrović Breakdown of academic impact, for papers by Noel Somasundaram Breakdown of academic impact, for papers by Shoroq M. Altawalbeh Breakdown of academic impact, for papers by P.-O. Lang
Rankless by CCL
2026